Uremic Middle Molecules Exist and Are Biologically Active
Overview
Authors
Affiliations
The membrane perspective of uraemic toxins: which ones should, or can, be removed?.
Bowry S, Kotanko P, Himmele R, Tao X, Anger M Clin Kidney J. 2022; 14(Suppl 4):i17-i31.
PMID: 34987783 PMC: 8711755. DOI: 10.1093/ckj/sfab202.
Sell D, CARLSON E, Monnier V Diabetologia. 1993; 36(10):936-41.
PMID: 8243873 DOI: 10.1007/BF02374476.
Peritoneal dialysability of "uraemic substances".
TARABA I, Spustova V, Dzurik R, Petranyi G Int Urol Nephrol. 1981; 13(2):193-8.
PMID: 7327895 DOI: 10.1007/BF02082064.
Middle molecular substances in acute renal failure.
Mydlik M, Spustova V, Dzurik R, Derzsiova K Int Urol Nephrol. 1982; 14(1):67-73.
PMID: 7118489 DOI: 10.1007/BF02082386.
Recent advances in the pathogenesis and nutritional treatment of chronic uremia.
Furst P, Alvestrand A, Bergstrom J Z Ernahrungswiss. 1982; 21(3):175-90.
PMID: 6293211 DOI: 10.1007/BF02028811.